Today: 27 June 2026
Visa stock slips in regular session as traders brace for CPI after jobless-claims check
12 February 2026
1 min read

Visa stock slips in regular session as traders brace for CPI after jobless-claims check

New York, Feb 12, 2026, 11:28 (EST) — Regular session

  • Visa slipped roughly 0.5% to trade near $328 late in the morning.
  • Fresh U.S. labor numbers landed, leaving investors to recalibrate ahead of Friday’s CPI release.
  • This week, the stock turned ex-dividend, setting up shareholders for a $0.67 payout on March 2.

Visa Inc slipped roughly 0.5% to $327.68 late Thursday morning, trading below Wednesday’s $329.24 close. Shares moved between $327.32 and $332.04 after the open.

The payment network, which pulls in fees every time a card transaction goes through its rails, tends to mirror consumer spending patterns. U.S. macro data has taken center stage again—investors aren’t hesitating to slash positions in stocks that require smooth, uninterrupted growth to back up their valuations.

U.S. jobless claims edged down to 227,000 last week, missing the 222,000 figure economists in the Reuters poll had penciled in. “Claims are well within the recent range over the last two years,” noted Carl Weinberg, chief economist at High Frequency Economics. Stephen Stanley of Santander U.S. Capital Markets called the numbers a return to the territory seen for years. Reuters

Stocks struggled across the board. The SPDR S&P 500 ETF dropped roughly 0.8%, while the Invesco QQQ Trust—tracking the Nasdaq 100—fell about 1.3%.

Mastercard slipped roughly 0.5%, while American Express fell harder, down 2.1%. Visa’s peers weren’t spared the drop either.

Visa shares started trading ex-dividend on Feb. 10, so anyone picking up the stock from that point won’t qualify for the upcoming $0.67 per share payout. That dividend is scheduled for March 2, according to dividend figures.

The most recent substantial update from the company came Jan. 29, when it topped Wall Street’s first-quarter profit and revenue forecasts, thanks to a holiday-fueled jump in card spending. Global payment volumes climbed 8% on a constant-dollar basis—excluding currency moves—while cross-border volumes posted 12% growth, a slowdown compared with the prior year. Finance chief Chris Suh told Reuters tariffs hadn’t had any material effect on results.

Cross-border volume’s a pulse-check for travel and trade spending—key spots in the payments cycle right now. If that number slips, the impact tends to ripple through group sentiment fast.

Still, a rates shock looms as a near-term risk for Visa and its payment peers. Should inflation data run hotter than traders expect, the timeline for Fed cuts could get pushed further out, prompting a rethink on stocks priced for steady growth. And if consumers start to pull back, that hit will filter into payment volumes sooner or later.

All eyes now turn to Friday, with the U.S. January consumer price index landing at 8:30 a.m. ET—a data drop that’s been known to rattle both rate bets and the market’s overall tone.

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors.

Stock Market Today

  • Telix Pharmaceuticals and Two Australian Insider-Led Growth Stocks Highlighted
    June 27, 2026, 11:07 AM EDT. Telix Pharmaceuticals (ASX:TLX), a A$5.2 billion biopharmaceutical firm specializing in radiopharmaceuticals for cancer imaging and treatment, draws growth-focused investors despite ongoing losses. The company reported US$621.9 million revenue from Precision Medicine and relies heavily on its oncology pipeline with products like Illuccix and late-stage candidates TLX591 and TLX101. Key risks include high R&D costs, regulatory scrutiny, pricing pressures, and trial dependencies. Also featured are two Australian insider-led growth stocks identified by the Fast Growing Stocks With High Insider Ownership screener, highlighting firms with aligned management-shareholder interests amid mixed inflation and cautious central bank policies.

Latest articles

GameStop (NYSE:GME) holds close to cash levels after company guides for $600 million in EBITDA

GameStop (NYSE:GME) holds close to cash levels after company guides for $600 million in EBITDA

27 June 2026
GameStop surged 3.57% to $21.76 and jumped after hours as it forecast FY2026 adjusted EBITDA above $600 million, nearly doubling from 2025; with a $9.76 billion market cap now close to its $9.7 billion in cash, securities, digital assets, and collateral, investors are weighing whether GameStop’s cash-rich balance sheet can support equity while Ryan Cohen pursues an eBay bid.
ImmunityBio (NASDAQ:IBRX) trades after post-Russell spike with 46% more volume

ImmunityBio (NASDAQ:IBRX) trades after post-Russell spike with 46% more volume

27 June 2026
ImmunityBio surged 11.8% to $8.71 on Friday with volume tripling its average, as Russell index reconstitution took effect; Monday’s trading will reveal if demand persists or if the spike was driven by index flows, with no imminent company events and recent insider selling accounting for just 0.06% of Friday’s volume.
Lucid (NASDAQ:LCID) jumps, adding about $312 million after $158 million cost plan

Lucid (NASDAQ:LCID) jumps, adding about $312 million after $158 million cost plan

27 June 2026
Lucid surged 15.6% Friday, adding $312 million in equity value—almost double the $158 million in annualized savings from this week’s restructuring plan that cut 18% of its U.S. workforce. Friday’s volume equaled 54% of reported short interest, but the rally outpaced cost-cutting fundamentals, leaving less room for further gains based solely on headcount cuts.
Court ruling on student loans hits private lenders’ health grad loan push

Court ruling on student loans hits private lenders’ health grad loan push

27 June 2026
Judge blocks narrow “professional degree” rule, letting more health-care grad students keep higher federal loan caps; $7.87B in 2023-24 borrowing above new limits remains in federal market, trimming but not eliminating the $4.5B-$5B annual private loan growth Sallie Mae projected from Grad PLUS loan cuts.
US Economic Calendar Today: Stock Futures Hold Steady as Traders Eye Fed Speeches, Treasury Buyback and Delayed Jobs Data
Previous Story

US Economic Calendar Today: Stock Futures Hold Steady as Traders Eye Fed Speeches, Treasury Buyback and Delayed Jobs Data

Uber stock: Tuesday test looms after Uber Eats targets $1 billion boost in Europe
Next Story

Uber stock: Tuesday test looms after Uber Eats targets $1 billion boost in Europe

Go toTop